1
|
Haaser T, Lahmi L, Osman D, Gesbert C, Cheval V, Constantinides Y, de Crevoisier R, Dejean C, Escande A, Ghannam Y, Lorchel F, Thureau S, Lagrange JL, Durdux C, Huguet F. [Ethical stakes of information in radiation oncology: Thinking the risk and building the therapeutic alliance]. Cancer Radiother 2023; 27:480-486. [PMID: 37573195 DOI: 10.1016/j.canrad.2023.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/06/2023] [Accepted: 06/07/2023] [Indexed: 08/14/2023]
Abstract
Informing patients before receiving radiation therapy is a fundamental ethical imperative. As a condition of the possibility of autonomy, information allows people to make health decisions concerning themselves, which is required by French law. This information includes in particular the potential risks due to radiation therapy. It is therefore necessary to think about what risk is, and how to define and assess it, in order to finally communicate it. The practice of informing people involves many ethical issues relating to the very content of the information, the form in which it is transmitted or even the intention that leads the health professional to say (or not to say) the risk. The transmission of information also questions the way to build a relationship of trust with the patients and how to integrate their own representations about these treatments. Between the risks of paternalism or even defensive medicine, this practice is at the heart of our professional practice.
Collapse
Affiliation(s)
- T Haaser
- Service d'oncologie radiothérapie, hôpital Haut Lévêque, centre hospitalier universitaire de Bordeaux, avenue Magellan, 33600 Pessac, France; Centre éthique et recherche en santé de Bordeaux, centre hospitalier universitaire de Bordeaux, Bordeaux, France; EA 4574 sciences, philosophie, humanités, universités de Bordeaux et Bordeaux Montaigne, Pessac, France.
| | - L Lahmi
- Service d'oncologie radiothérapie, institut Curie, Paris, France
| | - D Osman
- Service de médecine intensive-réanimation, hôpital de Bicêtre, AP-HP, DMU Correve, université Paris-Saclay, Le Kremlin-Bicêtre, Paris, France
| | - C Gesbert
- Direction de la qualité, des services aux patients et des parcours, centre hospitalier de Versailles, Versailles, France
| | - V Cheval
- Service universitaire d'oncologie radiothérapie, centre Oscar-Lambret, faculté de médecine Henri-Warembourg, laboratoire CRIStAL, UMR9189, université de Lille, Lille, France
| | - Y Constantinides
- Espace éthique Île-de-France, Paris université Sorbonne Nouvelle, Paris, France
| | - R de Crevoisier
- Service d'oncologie radiothérapie, centre Eugène-Marquis, Rennes, France
| | - C Dejean
- Service d'oncologie radiothérapie, unité de physique médicale, centre Antoine-Lacassagne, Nice, France
| | - A Escande
- Service universitaire d'oncologie radiothérapie, centre Oscar-Lambret, faculté de médecine Henri-Warembourg, laboratoire CRIStAL, UMR9189, université de Lille, Lille, France
| | - Y Ghannam
- Service d'oncologie radiothérapie, hôpital Tenon, centre de recherche Saint-Antoine UMR_S 938, institut universitaire de cancérologie, AP-HP, Sorbonne université, Paris, France
| | - F Lorchel
- Service d'oncologie radiothérapie, centre hospitalier universitaire Lyon-Sud, Lyon, France; Centre d'oncologie radiothérapie et oncologie de Mâcon (Orlam), Mâcon, France
| | - S Thureau
- Service d'oncologie radiothérapie, Quantis Litis EA 4108, centre Henri-Becquerel, Rouen, France
| | - J L Lagrange
- Université Paris-Est Créteil Val-de-Marne, Paris, France
| | - C Durdux
- Service d'oncologie radiothérapie, hôpital européen Georges-Pompidou, Paris, France
| | - F Huguet
- Service d'oncologie radiothérapie, hôpital Tenon, centre de recherche Saint-Antoine UMR_S 938, institut universitaire de cancérologie, AP-HP, Sorbonne université, Paris, France
| |
Collapse
|
2
|
Nait-Achour O, Cucchiaro S, Nardin S, Brusadin G. [Radiation TherapisTs Radiographer (RTTs) and risk management in radiotherapy: An international survey]. Cancer Radiother 2022; 26:846-850. [PMID: 35961930 DOI: 10.1016/j.canrad.2022.06.006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/10/2022] [Accepted: 06/17/2022] [Indexed: 11/27/2022]
Abstract
PURPOSE In order to study the role perception and the effective involvement of Radiation TherapisTs (RTTs) in risk management in radiotherapy, a survey was developed and distributed in five countries (France, Switzerland, Belgium, Ireland, the Netherlands). MATERIALS AND METHODS The article presents the results of this survey and the comparison between the different countries. RESULTS Overall, the results of the survey show a good involvement and perception of the RTTs around the risk management approach, although training in this area has yet to be systematized. CONCLUSION Although with differences in the results between the participating countries, the survey seems to highlight the deployment of preventive actions that are evaluated as not very effective by the respondents and by the international scientific literature.
Collapse
Affiliation(s)
- O Nait-Achour
- Département IMRT, Lycée Antoine-de-Saint-Exupéry, 2, rue Henri-Matisse, 94000 Créteil, France
| | - S Cucchiaro
- Service de radiothérapie, CHU Liège, 1, avenue de l'Hôpital, 4000 Liège, Belgique
| | - S Nardin
- Service de radiothérapie, Centre de Haute Énergie, 10, boulevard Pasteur, 06000 Nice, France
| | - G Brusadin
- Direction qualité et gestion des risques, France Gustave-Roussy, 114, rue Edouard-Vaillant, 94805 Villejuif cedex, France.
| |
Collapse
|
3
|
Klausner G, Blais E, Martin C, Biau J, Jumeau R, Canova CH, Lyothier A, Slama Y, Jenny C, Chéa M, Zilli T, Miralbell R, Thariat J, Maingon P, Troussier I. De la construction du bunker à la prise en charge du patient : contrôles qualité des techniques modernes de radiothérapie. Cancer Radiother 2019; 23:248-254. [DOI: 10.1016/j.canrad.2018.07.142] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2018] [Revised: 07/14/2018] [Accepted: 07/19/2018] [Indexed: 10/26/2022]
|
4
|
Martin C, Jumeau R, Blais E, Canova CH, Klausner G, Dumas R, Rouger A, Pariente F, Lyothier A, Slama Y, Dol J, Perret J, Jenny C, Chea M, Pasdeloup F, Maingon P, Troussier I. Mise en place d’une politique de qualité et de sécurité lors de l’installation d’un nouvel équipement dans un service de radiothérapie. Cancer Radiother 2019; 23:50-57. [DOI: 10.1016/j.canrad.2018.04.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/22/2018] [Revised: 03/29/2018] [Accepted: 04/17/2018] [Indexed: 10/27/2022]
|
5
|
Malicki J, Bly R, Bulot M, Godet JL, Jahnen A, Krengli M, Maingon P, Prieto Martin C, Przybylska K, Skrobała A, Valero M, Jarvinen H. Patient safety in external beam radiotherapy, results of the ACCIRAD project: Current status of proactive risk assessment, reactive analysis of events, and reporting and learning systems in Europe. Radiother Oncol 2017; 123:29-36. [PMID: 28351525 DOI: 10.1016/j.radonc.2017.02.016] [Citation(s) in RCA: 14] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/27/2016] [Revised: 02/01/2017] [Accepted: 02/28/2017] [Indexed: 11/30/2022]
Abstract
PURPOSE To describe the current status of implementation of European directives for risk management in radiotherapy and to assess variability in risk management in the following areas: 1) in-country regulatory framework; 2) proactive risk assessment; (3) reactive analysis of events; and (4) reporting and learning systems. MATERIAL AND METHODS The original data were collected as part of the ACCIRAD project through two online surveys. RESULTS Risk assessment criteria are closely associated with quality assurance programs. Only 9/32 responding countries (28%) with national regulations reported clear "requirements" for proactive risk assessment and/or reactive risk analysis, with wide variability in assessment methods. Reporting of adverse error events is mandatory in most (70%) but not all surveyed countries. CONCLUSIONS Most European countries have taken steps to implement European directives designed to reduce the probability and magnitude of accidents in radiotherapy. Variability between countries is substantial in terms of legal frameworks, tools used to conduct proactive risk assessment and reactive analysis of events, and in the reporting and learning systems utilized. These findings underscore the need for greater harmonisation in common terminology, classification and reporting practices across Europe to improve patient safety and to enable more reliable inter-country comparisons.
Collapse
Affiliation(s)
- Julian Malicki
- Department of Electroradiology, University of Medical Sciences, Poznan, Poland; Greater Poland Cancer Centre, Poznan, Poland.
| | - Ritva Bly
- Radiation and Nuclear Safety Authority, Helsinki, Finland
| | | | | | - Andreas Jahnen
- Luxembourg Institute of Science and Technology (LIST), Esch/Alzette, Luxembourg
| | - Marco Krengli
- Department of Translational Medicine, University of "Piemonte Orientale", Novara, Italy(1)
| | - Philippe Maingon
- Hôpitaux Universitaires Pitié Salpêtrière - Charles Foix, Paris, France(1)
| | | | | | - Agnieszka Skrobała
- Department of Electroradiology, University of Medical Sciences, Poznan, Poland; Greater Poland Cancer Centre, Poznan, Poland
| | - Marc Valero
- Nuclear Safety Authority - ASN, Paris, France
| | - Hannu Jarvinen
- Radiation and Nuclear Safety Authority, Helsinki, Finland
| |
Collapse
|
6
|
Identification et analyse des prises de décision dans la chaîne de soins en radiothérapie. PSYCHO-ONCOLOGIE 2016. [DOI: 10.1007/s11839-016-0587-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
7
|
Lisbona A, Valero M. [Practical risk analysis]. Cancer Radiother 2015; 19:629-33. [PMID: 26362221 DOI: 10.1016/j.canrad.2015.05.010] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/11/2015] [Revised: 05/18/2015] [Accepted: 05/18/2015] [Indexed: 11/29/2022]
Abstract
Risk analysis is typically considered from two complementary points of view: predictive analysis performed prior, and retrospective analysis, which follows the internal reporting of adverse situations or malfunctions, both on the organizational and material or human aspects. The purpose of these additional analyzes is to ensure that planned or implemented measures allow to keep risks to a level deemed tolerable or acceptable at a given time and in a given situation. Where a risk is deemed unacceptable, risk reduction measures should be considered (prevention, limiting the consequences and protection).
Collapse
Affiliation(s)
- A Lisbona
- Institut de cancérologie de l'Ouest, boulevard Jacques-Monod, 44805 Saint-Herblain cedex, France.
| | - M Valero
- Autorité de sûreté nucléaire, 15, rue Louis-Lejeune, 92541 Montrouge cedex, France
| |
Collapse
|
8
|
Mazeron R, Aguini N, Rivin Del Campo E, Dumas I, Gensse MC, Brusadin G, Lefkopoulos D, Deutsch E, Haie-Meder C. Implementation of the global risk analysis in pulsed-dose rate brachytherapy: methods and results. Cancer Radiother 2015; 19:89-97. [PMID: 25600666 DOI: 10.1016/j.canrad.2014.11.002] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/22/2014] [Revised: 09/26/2014] [Accepted: 11/05/2014] [Indexed: 11/29/2022]
Abstract
PURPOSE To report the application of the global risk analysis (GRA) in the pulsed-dose rate (PDR) brachytherapy workflow. MATERIAL AND METHODS Analyses were led by a multidisciplinary working group established within the unit with the guidance of a quality engineer. First, a mapping of hazardous situations was developed as a result of interactions between the patient workflow for a treatment using PDR brachytherapy split into 51 sub-phases with a comprehensive list of the hazards that he/she faces (44). Interactions, when relevant, were sorted by level of priority: to be treated immediately, secondarily (the group is not entitled to treat the situation), or later (safe situation). Secondly, for each high priority dangerous situation, scenarios were developed to anticipate their potential consequences. Criticality was assessed, using likelihood and severity scales and a matrix, which allocated risks into categories: acceptable (C1), tolerable under control (C2) and unacceptable (C3). Then, corrective actions were proposed and planned when relevant, after assessment of their feasibility with a scale of effort. Finally, the criticality of the scenarios was reevaluated, taking into account the implementation of these actions, leading to a residual risk mapping, which could trigger additional proposals of actions. RESULTS Two thousand one hundred and eighty-four potential interactions between the list of hazards and the workflow were analyzed. Mapping of dangerous situations identified 213 relevant interactions, from which 61 were considered with high priority. One hundred and twenty-six scenarios were generated: 68 with a low criticality (74.3%), 58 with an intermediate score (25.7%). No scenario with the highest criticality was individualized. Twenty-one corrective actions were planned. Mapping of residual risk resulted in the disappearance of most C2 risks, leaving 5 C2 scenarios (4%), for which four monitoring indicators were implemented in addition to the corrected actions decided on. CONCLUSION The implementation of the GRA appeared feasible, and led to implement 21 corrective actions, based on scenarios and not on incidents.
Collapse
Affiliation(s)
- R Mazeron
- Radiation Oncology, Gustave-Roussy Cancer Campus Grand Paris, 114, rue Édouard-Vaillant, 97805 Villejuif cedex, France.
| | - N Aguini
- Quality and risk Assessment, Gustave-Roussy Cancer Campus Grand Paris, 114, rue Édouard-Vaillant, 97805 Villejuif cedex, France
| | - E Rivin Del Campo
- Radiation Oncology, Gustave-Roussy Cancer Campus Grand Paris, 114, rue Édouard-Vaillant, 97805 Villejuif cedex, France
| | - I Dumas
- Medical physics, Gustave-Roussy Cancer Campus Grand Paris, 114, rue Édouard-Vaillant, 97805 Villejuif cedex, France
| | - M-C Gensse
- Radiation Oncology, Gustave-Roussy Cancer Campus Grand Paris, 114, rue Édouard-Vaillant, 97805 Villejuif cedex, France
| | - G Brusadin
- Radiation Oncology, Gustave-Roussy Cancer Campus Grand Paris, 114, rue Édouard-Vaillant, 97805 Villejuif cedex, France
| | - D Lefkopoulos
- Medical physics, Gustave-Roussy Cancer Campus Grand Paris, 114, rue Édouard-Vaillant, 97805 Villejuif cedex, France
| | - E Deutsch
- Radiation Oncology, Gustave-Roussy Cancer Campus Grand Paris, 114, rue Édouard-Vaillant, 97805 Villejuif cedex, France
| | - C Haie-Meder
- Radiation Oncology, Gustave-Roussy Cancer Campus Grand Paris, 114, rue Édouard-Vaillant, 97805 Villejuif cedex, France
| |
Collapse
|